Free Submission Public Relations &
Deutsch English


Omnicare Declares Quarterly Cash Dividend

Print article Print article
Copyright © Thomson Reuters 2013. All rights reserved.
2013-02-15 14:01:59 -

CINCINNATI, February 15, 2013 - Omnicare, Inc. (NYSE:OCR), announced today that
its board of directors approved a quarterly cash dividend of $0.14 per share on
its common stock.  The dividend is payable on March 22, 2013 to stockholders of
record on March 7, 2013.

About Omnicare

Omnicare, Inc., a Fortune 400 company based in Cincinnati, Ohio, provides
comprehensive pharmaceutical services to patients and providers across North
America.  As the market-leader in professional pharmacy, related consulting and
data management services for skilled nursing, assisted living and other chronic
care institutions, Omnicare leverages its unparalleled clinical insight into the
geriatric market along with some of the industry's most innovative technological
capabilities to the benefit of its long-term care customers.  Omnicare also
provides key commercialization services for the bio-pharmaceutical industry and
end-of-life disease management through its 
Specialty Care Group.  For more information, visit # # # Contact: Patrick C. Lee (513) 719-1507 This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Omnicare via Thomson Reuters ONE [HUG#1678516]

Press Information:

Contact Person:

Disclaimer: © 2014 Thomson Reuters. The press releases or report contained herein is protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Thomson Reuters's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact | BidVertiser